Old Web
English
Sign In
Acemap
>
authorDetail
>
Erik Sjoeland
Erik Sjoeland
Janssen Pharmaceutica
Internal medicine
Rivaroxaban
Medicine
Retrospective cohort study
Atrial fibrillation
2
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Healthcare costs before and after stroke in non-valvular atrial fibrillation patients who initiated treatment with rivaroxaban or warfarin.
2021
Journal of Medical Economics
Dejan Milentijevic
Jennifer H Lin
Yen-Wen Chen
Emily Kogan
Shubham Shrivastava
Erik Sjoeland
Mark J. Alberts
Show All
Source
Cite
Save
Citations (1)
Risk of Stroke Outcomes in Atrial Fibrillation Patients Treated with Rivaroxaban and Warfarin.
2021
Journal of Stroke & Cerebrovascular Diseases
Dejan Milentijevic
Jennifer H Lin
Nancy Connolly
Yen-Wen Chen
Emily Kogan
Shubham Shrivastava
Erik Sjoeland
Mark J. Alberts
Show All
Source
Cite
Save
Citations (0)
1